Monomethyl auristatin E intermediate-16 is an intermediate in the synthesis of Monomethyl auristatin E (MMAE), which is a microtubule/tubulin polymerization inhibitor with anticancer activity and is widely used as a cytotoxic payload in antibody-drug conjugates (ADCs).